Latest Commercialization News

Page 285 of 497
Ashley Services Group reported a 60% jump in net profit for FY25 despite a 7.3% revenue decline, focusing on debt reduction and operational efficiency to fuel future growth.
Victor Sage
Victor Sage
27 Aug 2025
Clever Culture Systems has validated and launched an AI-driven analysis module for smaller contact plates, significantly expanding its pharmaceutical market reach and recurring revenue potential.
Ada Torres
Ada Torres
27 Aug 2025
MyEco Group Ltd reported an 8.6% revenue increase to $15.7 million in FY25, driven by strong growth in its MyEco® branded products and improved margins. The company cut its net loss by nearly half, supported by operational restructuring and expanding market presence.
Victor Sage
Victor Sage
27 Aug 2025
Australian Finance Group Ltd (AFG) reported a 21% rise in statutory net profit after tax to $35 million for FY25, driven by record broker numbers and loan book growth. The company declared a fully franked final dividend of 5.3 cents per share, underscoring strong shareholder returns.
Claire Turing
Claire Turing
27 Aug 2025
Fleetwood Limited delivered a robust FY25 performance with significant earnings growth and a strong dividend increase, while outlining a confident outlook for FY26 despite challenges in its RV Solutions segment.
Victor Sage
Victor Sage
27 Aug 2025
First Graphene Limited’s partnership with Halocell Energy and QUT has yielded a breakthrough in perovskite solar cells, doubling efficiency to 30.6% while cutting production costs by up to 80%. This innovation paves the way for scalable, low-cost solar solutions across multiple industries.
Maxwell Dee
Maxwell Dee
27 Aug 2025
Terragen Holdings reported a $3.72 million loss for FY25, impacted by drought and lower revenues, while launching dry probiotic products targeting feedlots and completing a $4.76 million equity raise.
Ada Torres
Ada Torres
27 Aug 2025
Cleo Diagnostics reported a $4 million loss for FY2025 while making significant strides toward FDA approval of its novel ovarian cancer blood test. The company is progressing clinical trials and scaling manufacturing in preparation for market entry.
Ada Torres
Ada Torres
26 Aug 2025
CVC Limited reports a stable FY2025 profit alongside a robust landbank poised for significant value uplift, targeting a net tangible asset per share of $5.75 through strategic rezoning and development.
Eva Park
Eva Park
26 Aug 2025
Hazer Group has reported a remarkable FY25 performance with revenues more than doubling and losses slashed by 60%, underpinned by a strategic partnership with KBR and early commercial revenues.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Hazer Group Limited reported a 124% surge in revenues to $8.5 million for FY25, driven by government grants, while cutting its net loss by 60%. The company advanced its proprietary methane pyrolysis technology, secured a strategic alliance with KBR, and made progress on key projects in Canada and Japan.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Elanor Commercial Property Fund reported a statutory loss for FY25 but delivered a 6.9% rise in Funds from Operations, while rejecting an unsolicited takeover offer from the Lederer Group.
Eva Park
Eva Park
26 Aug 2025